Loading clinical trials...
Loading clinical trials...
A Phase III Trial Evaluating the Efficacy and Safety of the House Dust Mite (HDM) Sublingual Immunotherapy (SLIT)-Tablet in Children and Adolescents (5-17 Years) With HDM Allergic Asthma
Conditions
Interventions
HDM SLIT-tablet
Placebo
Locations
64
United States
Miami Clinical Research
Miami, Florida, United States
Columbus Regional Research Institute
Columbus, Georgia, United States
Respiratory Medicine Research Institute of MI
Ypsilanti, Michigan, United States
Private Clinic
Bangor, Pennsylvania, United States
Allergy Consultants
Verona, Pennsylvania, United States
TTS research
Boerne, Texas, United States
Start Date
February 22, 2018
Primary Completion Date
May 18, 2022
Completion Date
May 31, 2022
Last Updated
October 19, 2023
Lead Sponsor
ALK-Abelló A/S
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions